TRANSGENE SA (TNG.PA) Fundamental Analysis & Valuation

EPA:TNG • FR0005175080

Current stock price

0.764 EUR
-0.01 (-0.91%)
Last:

This TNG.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TNG.PA Profitability Analysis

1.1 Basic Checks

  • TNG had negative earnings in the past year.
  • TNG had a negative operating cash flow in the past year.
  • In the past 5 years TNG always reported negative net income.
  • In the past 5 years TNG always reported negative operating cash flow.
TNG.PA Yearly Net Income VS EBIT VS OCF VS FCFTNG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • TNG has a Return On Assets (-27.03%) which is in line with its industry peers.
  • With a decent Return On Equity value of -30.82%, TNG is doing good in the industry, outperforming 60.71% of the companies in the same industry.
Industry RankSector Rank
ROA -27.03%
ROE -30.82%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNG.PA Yearly ROA, ROE, ROICTNG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for TNG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNG.PA Yearly Profit, Operating, Gross MarginsTNG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. TNG.PA Health Analysis

2.1 Basic Checks

  • TNG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TNG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TNG.PA Yearly Shares OutstandingTNG.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TNG.PA Yearly Total Debt VS Total AssetsTNG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • TNG has an Altman-Z score of 6.78. This indicates that TNG is financially healthy and has little risk of bankruptcy at the moment.
  • TNG has a better Altman-Z score (6.78) than 73.81% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that TNG is not too dependend on debt financing.
  • The Debt to Equity ratio of TNG (0.01) is better than 77.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 6.78
ROIC/WACCN/A
WACC7.94%
TNG.PA Yearly LT Debt VS Equity VS FCFTNG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • TNG has a Current Ratio of 9.62. This indicates that TNG is financially healthy and has no problem in meeting its short term obligations.
  • TNG has a better Current ratio (9.62) than 91.67% of its industry peers.
  • A Quick Ratio of 9.62 indicates that TNG has no problem at all paying its short term obligations.
  • The Quick ratio of TNG (9.62) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 9.62
Quick Ratio 9.62
TNG.PA Yearly Current Assets VS Current LiabilitesTNG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TNG.PA Growth Analysis

3.1 Past

  • TNG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.71%, which is quite good.
  • The Revenue has grown by 12.76% in the past year. This is quite good.
  • The Revenue has been decreasing by -6.00% on average over the past years.
EPS 1Y (TTM)10.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.58%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y-11.82%
Revenue growth 5Y-6%
Sales Q2Q%-13.29%

3.2 Future

  • TNG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.98% yearly.
  • Based on estimates for the next years, TNG will show a very strong growth in Revenue. The Revenue will grow by 42.48% on average per year.
EPS Next Y-16.67%
EPS Next 2Y-27.48%
EPS Next 3Y17.57%
EPS Next 5Y-9.98%
Revenue Next Year9.82%
Revenue Next 2Y16.78%
Revenue Next 3Y72.19%
Revenue Next 5Y42.48%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TNG.PA Yearly Revenue VS EstimatesTNG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
TNG.PA Yearly EPS VS EstimatesTNG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. TNG.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TNG. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TNG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNG.PA Price Earnings VS Forward Price EarningsTNG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNG.PA Per share dataTNG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TNG's earnings are expected to grow with 17.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.48%
EPS Next 3Y17.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TNG.PA Dividend Analysis

5.1 Amount

  • No dividends for TNG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TNG.PA Fundamentals: All Metrics, Ratios and Statistics

TRANSGENE SA

EPA:TNG (4/14/2026, 3:29:01 PM)

0.764

-0.01 (-0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-24
Earnings (Next)04-29
Inst Owners0.26%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap209.48M
Revenue(TTM)6.86M
Net Income(TTM)-37.52M
Analysts82.86
Price Target1.5 (96.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.64%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.55
P/FCF N/A
P/OCF N/A
P/B 1.72
P/tB 1.72
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.03
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.03%
ROE -30.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.5%
Cap/Sales 12.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.62
Quick Ratio 9.62
Altman-Z 6.78
F-Score5
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)157.5%
Cap/Depr(5y)117.58%
Cap/Sales(3y)32.54%
Cap/Sales(5y)23.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.58%
EPS Next Y-16.67%
EPS Next 2Y-27.48%
EPS Next 3Y17.57%
EPS Next 5Y-9.98%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y-11.82%
Revenue growth 5Y-6%
Sales Q2Q%-13.29%
Revenue Next Year9.82%
Revenue Next 2Y16.78%
Revenue Next 3Y72.19%
Revenue Next 5Y42.48%
EBIT growth 1Y1.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-15.84%
EBIT Next 3Y3.71%
EBIT Next 5YN/A
FCF growth 1Y-42.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.32%
OCF growth 3YN/A
OCF growth 5YN/A

TRANSGENE SA / TNG.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TRANSGENE SA (TNG.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TNG.PA.


What is the valuation status of TRANSGENE SA (TNG.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to TRANSGENE SA (TNG.PA). This can be considered as Overvalued.


What is the profitability of TNG stock?

TRANSGENE SA (TNG.PA) has a profitability rating of 1 / 10.


How financially healthy is TRANSGENE SA?

The financial health rating of TRANSGENE SA (TNG.PA) is 6 / 10.